Validoxylamine A

CAS: 38665-10-0

Ref. 3D-NBA66510

Produktinformation

• Name: Validoxylamine A
• Synonyme: 1,5,6-Trideoxy-5-(hydroxymethyl)-1-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl]amino]-<span class="text-smallcaps">D</span>-chiro-inositol, 4-(Hydroxymethyl)-6-((2,3,4-trihydroxy-5-(hydroxymethyl)cyclohexyl)amino)-4-cyclohexene-1,2,3-triol, <span class="text-smallcaps">D</span>-chiro-Inositol, 1,5,6-trideoxy-5-(hydroxymethyl)-1-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl]amino]-, <span class="text-smallcaps">D</span>-chiro-Inositol, 1,5,6-trideoxy-5-(hydroxymethyl)-1-[[4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl]amino]-, [1S-(1α,4α,5β,6α)]-, validoxylamine A

Beschreibung

Validoxylamine A is a medicinal compound that has been found to be an inhibitor of kinases, which are proteins that play a key role in cellular signaling pathways. This compound has been isolated from Chinese urine and has shown promise as an anti-cancer agent. Validoxylamine A has been shown to induce apoptosis, or programmed cell death, in tumor cells by inhibiting kinase activity. It also disrupts the cell cycle of cancer cells, leading to their death. Validoxylamine A is a potent inhibitor of both human and Chinese hamster kinases, making it a promising candidate for the development of new cancer therapies.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 335.35 g/mol
• Formel: C₁₄H₂₅NO₈
• Reinheit: Min. 95%